MedTrace Logo

DETECT: Target Volume for Rectal Endoluminal Radiation Boosting

NCT04927897 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-07-28

No results posted yet for this study

Summary

The aim of the study is to provide prospective data regarding microscopic tumor spread in all directions from the macroscopic tumor in pathology specimens, as seen by eye, and on imaging to define the target volume for endoluminal radiation boosting in rectal cancer patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Ultrasound

3D endorectal ultrasound.

DIAGNOSTIC_TEST

Rectoscopy

Rigid rectoscopy.

OTHER

Scan, e.g. CT (resection specimen)

For some patients, images of the resection specimen (note: NOT of the patients) during the pathological process will be acquired.

Sponsors & Collaborators

  • Maastricht University Medical Center

    collaborator OTHER

  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Maaike Berbée, MD, PhD · Maastro

  • Evert Van Limbergen, MD, PhD · Maastro

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-16
Primary Completion
2027-05-31
Completion
2027-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04927897 on ClinicalTrials.gov